NDC11 65862065105
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 65862-0651-05 | 65862-0651 |
| 65862-0651-5 | 65862-0651 |
| 65862-651-05 | 65862-651 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rivastigmine Tartrate | RIVASTIGMINE TARTRATE | Aurobindo Pharma Limited | c246a0e5-1e77-41ee-a7b3-384f21f2f2e0 | 2024-06-19 | Warnings, Adverse reactions | 65862-651-05 65862-651 65862065105 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.